Parkinson's Disease: Biomarkers

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on genomic and drug-response biomarkers in Parkinson’s disease.

June 17, 2020
Open Access

Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study

Parkinsonism & Related Disorders
Cèlia PainousYaroslau Compta
June 10, 2020

The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension

Parkinsonism & Related Disorders
Jose-Alberto PalmaHoracio Kaufmann
June 20, 2020

Gastrointestinal surgical procedures affect levodopa pharmacokinetics in Parkinson's disease

Parkinsonism & Related Disorders
Noriyuki MiyaueMasahiro Nomoto
June 7, 2020

The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications

Parkinsonism & Related Disorders
A SchragCLaSP consortium
June 5, 2020

Cancer frequency in patients with spinocerebellar ataxia type 10

Parkinsonism & Related Disorders
Débora B SchultzH A G Teive
June 24, 2020

Pilates method improves balance control in Parkinson's disease patients: An open-label clinical trial

Parkinsonism & Related Disorders
David Pereira MacielFernanda Martins Maia
July 2, 2020
Preprint

Non-allelic homologous recombination of Alu and LINE-1 elements generates somatic complexity in human genomes.

BioRxiv : the Preprint Server for Biology
G. PascarellaPiero Carninci
June 20, 2020

Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease

Parkinsonism & Related Disorders
Swati RaneThomas Grabowski
July 6, 2020

Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers

Parkinsonism & Related Disorders
Stephanie MangesiusWerner Poewe
July 1, 2020

The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson's disease

Neuroscience Letters
Nergis Selma AslanBensu Karahalil
June 13, 2020

Functional correlates of cognitive slowing in Parkinson's disease

Parkinsonism & Related Disorders
Guillaume GrolezCaroline Moreau
June 23, 2020
Open Access

Medical education in movement disorders during the COVID-19 pandemic

Parkinsonism & Related Disorders
José Rafael P ZuzuárreguiNicholas Galifianakis
June 14, 2020

Machine learning-assisted neurotoxicity prediction in human midbrain organoids

Parkinsonism & Related Disorders
Anna S MonzelJens C Schwamborn
June 25, 2020

Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy

Parkinsonism & Related Disorders
Anna SantaellaMarcel M Verbeek
July 6, 2020
Review

Medical management of myoclonus-dystonia and implications for underlying pathophysiology

Parkinsonism & Related Disorders
Conor FearonAlfonso Fasano
June 21, 2020

Hypersensitivity to atypical antipsychotics in dementia with Lewy bodies: is it common or rare?

Parkinsonism & Related Disorders
Jung-Min PyunSangYun Kim
June 27, 2020

A novel mutation in PSEN1 (p.Arg41Ser) in an Argentinian woman with early onset Parkinsonism

Parkinsonism & Related Disorders
Emilia M GattoAdrian G Turjanski
June 20, 2020

Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation

Parkinsonism & Related Disorders
Giovanna De MicheleAlessandro Filla

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-biomarkers/28ca42d2-e7b5-4c4f-9932-3384c44e101f